Tarsus Pharmaceuticals, Inc.
TARS
Clasificación en acciones
#4656
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions. Its leading investigational drug, TP-03, a novel treatment currently in Phase III trials, is being developed to address blepharitis specifically caused by Demodex mite infestations, as well as meibomian gland disease. Beyond this, Tarsus is also progressing TP-04 for rosacea and TP-05, which targets Lyme disease prevention and aims to reduce community-level malaria. A core element of its development strategy involves lotilaner, a compound utilized to tackle a variety of human diseases across diverse therapeutic areas, encompassing eye care, dermatology, and other medical fields. Established in 2016, the company maintains its headquarters in Irvine, California.
Precio por acción
$69.68
Capitalización bursátil
$3.26B
Cambio (1 día)
2.36%
Cambio (1 año)
-4.46%
País
US
Comercio Tarsus Pharmaceuticals, Inc. (TARS)
Categoría
Healthcare
EPS de Tarsus Pharmaceuticals, Inc. (TARS)
EPS a fecha de June 2026 TTM: $-1.09
Según los últimos informes financieros y el precio de las acciones de Tarsus Pharmaceuticals, Inc., el EPS actual de la empresa (TTM) es $-1.09. Al final del año 2023, la empresa tenía un EPS de $-4.62 un aumento con respecto a al EPS de 2022, que fue de $-2.52.
Historial de EPS de Tarsus Pharmaceuticals, Inc. desde 2018 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2026 (TTM) | $-1.09 | -64.50% |
| 2024 | $-3.07 | -33.55% |
| 2023 | $-4.62 | 83.33% |
| 2022 | $-2.52 | 276.12% |
| 2021 | $-0.67 | -49.24% |
| 2020 | $-1.32 | 450.00% |
| 2019 | $-0.24 | -22.58% |
| 2018 | $-0.31 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| $17.32 | -1,688.99% |
US
|
|
| $-7.98 | 632.11% |
US
|
|
| $-5.29 | 385.32% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -2,644.95% |
NL
|
